Workflow
继峰股份(603997) - 2022 Q1 - 季度财报
NBJFNBJF(SH:603997)2022-04-28 16:00

Financial Performance - The company's operating revenue for Q1 2022 was ¥4,203,846,520.73, representing a decrease of 7.25% compared to the same period last year [6] - The net profit attributable to shareholders of the listed company was -¥37,639,405.82, indicating a significant loss [6] - The diluted earnings per share for the period was -¥0.03, reflecting the impact of chip shortages and rising raw material prices [12] - The weighted average return on net assets was -0.81%, primarily due to the same adverse factors affecting profitability [8] - The company reported a comprehensive income total of CNY -13,024,371.57 for Q1 2022, contrasting with CNY 43,978,243.16 in Q1 2021 [28] - Basic earnings per share for Q1 2022 was CNY -0.03, down from CNY 0.13 in Q1 2021, reflecting the adverse financial performance [28] - Net profit attributable to shareholders of the parent company for Q1 2022 was CNY -37,639,405.82, compared to CNY 128,031,397.01 in Q1 2021, indicating a significant decline [27] Cash Flow and Liquidity - The net cash flow from operating activities was ¥175,310,752.42, with no applicable year-on-year comparison [6] - The net cash flow from operating activities was $175,310,752.42, a significant improvement compared to a net outflow of $25,837,429.65 in the previous period, indicating a positive operational performance [32] - Total cash inflow from investment activities amounted to $210,551,709.81, a substantial increase from $21,076,236.44 in the prior period, reflecting enhanced investment recovery efforts [32] - The net cash flow from investment activities was -$290,515,354.93, slightly improved from -$358,634,169.84, showing ongoing investment in growth despite cash outflows [32] - Cash inflow from financing activities totaled $483,031,392.52, down from $677,993,150.48, indicating a reduction in financing activities during the period [32] - The net cash flow from financing activities was -$36,781,991.82, contrasting with a positive net inflow of $154,263,394.47 in the previous period, suggesting tighter financing conditions [33] - The ending balance of cash and cash equivalents was $1,237,252,172.52, down from $1,416,315,531.85, reflecting a decrease in liquidity [33] Assets and Liabilities - The total assets at the end of the reporting period were ¥16,290,018,615.58, showing a slight increase of 0.50% from the end of the previous year [8] - Current assets totaled ¥6,799,783,791.79, up from ¥6,515,143,953.85 in the previous year, indicating a growth of approximately 4.37% [21] - Total liabilities reached ¥11,303,321,604.30, up from ¥11,210,619,754.01, indicating a rise of approximately 0.83% [23] - Short-term borrowings increased to ¥1,756,523,096.09 from ¥1,638,487,947.89, reflecting a growth of about 7.2% [23] - The company reported a decrease in long-term borrowings to ¥2,618,463,456.81 from ¥2,630,503,752.41, a decline of approximately 0.57% [23] - The company's total liabilities and equity amounted to CNY 16,290,018,615.58 as of the end of Q1 2022, compared to CNY 16,209,142,705.15 at the end of Q1 2021 [24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,377, with the largest shareholder holding 26.06% of the shares [13] - The company’s total equity attributable to shareholders of the parent company decreased to CNY 4,626,881,347.39 from CNY 4,644,817,545.49 in the previous year [24] Operational Challenges - The company faced challenges due to chip shortages and rising raw material prices, compounded by the impact of a new wave of COVID-19 [12] - The company reported non-operating income and expenses totaling -¥186,984.49, influenced by various non-recurring factors [9] Investment and R&D - Research and development expenses for Q1 2022 were CNY 76,761,878.60, a decrease from CNY 81,014,409.96 in Q1 2021, indicating a potential shift in investment strategy [27] - Cash outflow for investment activities was $501,067,064.74, compared to $379,710,406.28, showing increased capital expenditures for growth initiatives [32] - The company has not disclosed any new product developments or market expansion strategies in the provided reports [18]